8-K: Patterson Companies Shareholders Approve Acquisition by Patient Square Capital

Patterson Companies' shareholders have approved the acquisition of the company by Patient Square Capital at a special meeting held on April 1, 2025.

Summary

• Patterson Companies, Inc. held a Special Meeting of Shareholders on April 1, 2025, to vote on proposals related to its merger with Paradigm Parent, LLC, an indirect subsidiary of Patient Square Capital.
• Shareholders approved the merger agreement, with approximately 84% of outstanding shares represented at the meeting.
• The merger will result in Patterson becoming a private company, with shareholders receiving $31.35 per share in cash.
• Following the merger, Patterson's common stock will no longer be traded on the NASDAQ Global Select Market.
• The transaction is expected to close later in April 2025, subject to customary closing conditions.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive due to the successful shareholder approval of the acquisition and the anticipated benefits of becoming a private company under Patient Square Capital's ownership. However, there are inherent risks associated with the merger and the transition to private ownership.

Positives

• Shareholders approved the merger with a significant majority.
• The acquisition provides shareholders with a cash payment of $31.35 per share.
• Management believes the partnership with Patient Square Capital will enable continued investment, accelerated growth, and achievement of strategic priorities.

Negatives

• Patterson will cease to be a publicly traded company after the merger.
• The company will no longer be obligated to file periodic reports with the SEC after the merger.

Risks

• The inability to consummate the Merger within the anticipated time period, or at all, due to any reason, including the failure to obtain required regulatory approvals, satisfy the other conditions to the consummation of the Merger or complete necessary financing arrangements.
• The risk that the Merger disrupts our current plans and operations or diverts managements attention from its ongoing business.
• The effects of the Merger on our business, operating results, and ability to retain and hire key personnel and maintain relationships with customers, suppliers and others with whom we do business.
• The risk that our stock price may decline significantly if the Merger is not consummated.
• The nature, cost and outcome of any legal proceedings related to the Merger.

Future Outlook

Patterson expects the transaction to close later in April 2025, subject to customary closing conditions. Upon completion, Patterson will become a privately held company.

Management Comments

• Don Zurbay, Patterson's President and Chief Executive Officer, expressed gratitude to shareholders for their support and excitement about the partnership with Patient Square Capital.
• Management believes this collaboration will enable continued investment in serving customers, accelerating growth, and achieving strategic priorities.

Industry Context

The acquisition reflects the ongoing trend of private equity firms investing in the healthcare sector, seeking to leverage their expertise and capital to drive growth and improve operational efficiency within established companies.

Comparison to Industry Standards

• The acquisition price of $31.35 per share is a key metric for comparison against similar transactions in the distribution and healthcare sectors.
• Comparable companies in the distribution space, such as Henry Schein (HSIC) and McKesson (MCK), can be used as benchmarks to assess the valuation and strategic rationale of the acquisition.
• Patient Square Capital's investment aligns with the broader trend of private equity firms targeting companies with strong market positions and growth potential in the healthcare industry.

Stakeholder Impact

• Shareholders will receive $31.35 per share in cash.
• Employees may experience changes as the company transitions to private ownership.
• Customers and suppliers are expected to benefit from continued investment and growth under Patient Square Capital's ownership.

Next Steps

• The transaction is expected to close later in April 2025, subject to the satisfaction of certain customary closing conditions.
• Patterson will become a privately held company and its common stock will no longer be traded on the NASDAQ Global Select Market.

Key Dates

Keywords

Merger, Acquisition, Shareholders, Patient Square Capital, Patterson Companies, PDCO, NASDAQ, Private Company